Boston Scientific Corporation (BSX)
NYSE·Healthcare·Medical - Devices
$58.34
-2.68%
Mkt Cap $90.64B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 22, 2026 | $5.17B | $5.20B | +0.58% | $0.79 | $0.80 | +1.52% | — | — |
| Q1 2026 Feb 4, 2026 | $5.28B | $5.29B | +0.12% | $0.78 | $0.80 | +2.43% | — | — |
| Q4 2025 Oct 22, 2025 | $4.97B | $5.07B | +1.93% | $0.71 | $0.75 | +5.04% | — | — |
| Q3 2025 Jul 23, 2025 | $4.89B | $5.06B | +3.43% | $0.72 | $0.75 | +3.45% | — | — |
| Q2 2025 Apr 23, 2025 | $4.57B | $4.66B | +2.00% | $0.67 | $0.75 | +11.44% | — | — |
| Q1 2025 Feb 5, 2025 | $4.42B | $4.56B | +3.18% | $0.66 | $0.70 | +6.54% | — | — |
| Q4 2024 Oct 23, 2024 | $4.04B | $4.21B | +4.16% | $0.59 | $0.63 | +7.14% | — | — |
| Q3 2024 Jul 24, 2024 | $4.03B | $4.12B | +2.26% | $0.58 | $0.62 | +6.35% | — | — |
| Q2 2024 Apr 24, 2024 | $3.68B | $3.86B | +4.67% | $0.51 | $0.56 | +8.95% | — | — |
| Q1 2024 Jan 31, 2024 | $3.59B | $3.73B | +3.68% | $0.51 | $0.55 | +7.84% | — | — |
| Q4 2023 Oct 26, 2023 | $3.47B | $3.53B | +1.50% | $0.48 | $0.50 | +4.17% | — | — |
| Q3 2023 Jul 27, 2023 | $3.50B | $3.60B | +2.76% | $0.49 | $0.53 | +8.16% | — | — |
| Q2 2023 Apr 26, 2023 | $3.16B | $3.39B | +7.41% | $0.43 | $0.47 | +9.30% | — | — |
| Q1 2023 Feb 1, 2023 | $3.24B | $3.24B | -0.04% | $0.47 | $0.45 | -4.26% | — | — |
| Q4 2022 Oct 26, 2022 | $3.14B | $3.17B | +0.97% | $0.44 | $0.43 | -2.27% | — | — |
| Q3 2022 Jul 27, 2022 | $3.22B | $3.24B | +0.86% | $0.42 | $0.44 | +4.76% | — | — |
| Q2 2022 Apr 27, 2022 | $2.96B | $3.03B | +2.39% | $0.38 | $0.39 | +2.63% | — | — |
| Q1 2022 Feb 2, 2022 | $3.11B | $3.13B | +0.50% | $0.44 | $0.45 | +2.27% | — | — |
| Q4 2021 Oct 27, 2021 | $3.00B | $2.93B | -2.36% | $0.40 | $0.41 | +2.50% | — | — |
| Q3 2021 Jul 27, 2021 | $3.02B | $3.08B | +2.06% | $0.37 | $0.40 | +8.11% | — | — |